Form 4: Cardlytics Director John L. Klinck Jr. Buys $48,860 Worth of Shares

Director John L. Klinck Jr. of Cardlytics, Inc. (CDLX) purchased 14,000 shares of common stock at $3.49 per share on August 12, 2024.

Summary

• On August 12, 2024, John L. Klinck Jr., a director of Cardlytics, Inc. (CDLX), acquired 14,000 shares of common stock.
• The purchase price was $3.49 per share.
• Following the transaction, Klinck directly owns 67,593 shares of Cardlytics common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. An insider purchase is generally viewed as a positive sign, but the size of the purchase is not significant enough to drastically alter sentiment.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of the financial markets, providing transparency into the transactions of company insiders. They are closely watched by investors seeking insights into management's perspective on the company's value and future.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholders, as it may signal confidence from a company insider.

Key Dates